About RexahnClinical DevelopmentTechbologiesPatientsInvestor RelationsMedia Center


 

 

 

 

 

 

 

 

 

 

exahn Pharmaceuticals is a clinical stage biopharmaceutical company, comprised of a world-class team of professionals dedicated to the

 

discovery, development and commercialization of innovative treatments for cancer, CNS disorders, sexual dysfunction and other unmet medical needs. Innovative therapeutics and technologies come from a commitment to the wellness of the patients we serve.

 

February 17, 2010
Rexahn Pharmaceuticals Provides Key Goals for 2010
February 01, 2010
Rexahn Pharmaceuticals to Present at the 12th Annual Bio CEO & Investor Conference
January 19, 2010
Rexahn Pharmaceuticals Granted European Patent for Anti-cancer Compound RX-3117
December 14, 2009
Rexahn and TheraTarget Form Nano Science Research Collaboration
 

eikon.jpg cancernews.jpg mental.jpg